Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients

American Journal of Medicine

Volumn 126, Issue 10, 2013, Pages 925.e11-925.e22

  Ji, Linong ^a   Hu, Dayi ^a   Pan, Changyu ^b   Weng, Jianping ^c   Huo, Yong ^d   Ma, Changsheng ^e   Mu, Yiming ^b   Hao, Chuanming ^f   Ji, Qiuhe ^g   Ran, Xingwu ^h   Su, Benli ⁱ   Zhuo, Hanjing ^j   Fox, Keith A A ^k   Weber, Michael ^l   Zhang, Danyi ^j  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b 301 Military General Hospital   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d PEKING UNIVERSITY FIRST HOSPITAL   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

^f FUDAN UNIVERSITY   (China)

^g FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^h SICHUAN UNIVERSITY   (China)

ⁱ Da Lian Medical University Affiliated Hospital   (China)

^j VitalStrategic Research Institute   (United States)

^k UNIVERSITY OF EDINBURGH   (United Kingdom)

^l SUNY Downstate Medical Center   (United States)

more..

Author keywords

Cardiovascular risk factor; China; Dyslipidemia; Hyperglycemia; Hypertension; Type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE; BILE ACID SEQUESTRANT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; MEGLITINIDE; NICOTINIC ACID; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINA; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; COMORBIDITY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; DYSLIPIDEMIA; EDUCATIONAL STATUS; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OUTPATIENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 84884532930     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2013.02.035     Document Type: Article

References (36)

1. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
2. P.W. Wilson Diabetes mellitus and coronary heart disease Am J Kidney Dis 32 1998 S89 S100
3. H.C. McGill Jr., and C.A. McMahan Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group Am J Cardiol 82 1998 30T 36T
4. I.M. Stratton, A.I. Adler, and H.A. Neil Association of glycemia and macrovascular and microvascular complications in type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 2000 405 412
5. A. Juutilainen, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects Diabetes Care 28 2005 2901 2907
6. J.W. Smith, F.I. Marcus, and R. Serokman Prognosis of patients with diabetes mellitus after acute myocardial infarction Am J Cardiol 54 1984 718 721
7. U. Keil, A.D. Liese, and H.W. Hense Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984-1992. Monitoring Trends and Determinants in Cardiovascular Diseases Eur Heart J 19 1998 1197 1207
8. J. Lee, S. Ma, D. Heng, S.K. Chew, K. Hughes, and E.S. Tai Hypertension, concurrent cardiovascular risk factors and mortality: the Singapore Cardiovascular Cohort Study J Hum Hypertens 22 2008 468 474
9. G. Chen, F.A. McAlister, R.L. Walker, B.R. Hemmelgarn, and N.R. Campbell Cardiovascular outcomes in Framingham participants with diabetes: the importance of blood pressure Hypertension 57 2011 891 897
10. S.C. Smith Jr. Screening for high-risk cardiovascular disease: a challenge for the guidelines Arch Intern Med 170 2010 40 42
11. UK Prospective Diabetes Study Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
12. UK Prospective Diabetes Study (UKPDS) Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ 317 1998 703 713
13. K. Pyorala, T.R. Pedersen, and J. Kjekshus Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) Diabetes Care 20 1997 614 620
14. W. Yang, J. Lu, and J. Weng China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in China N Engl J Med 362 2010 1090 1101
15. The World Bank Toward a Healthy and Harmonious Life in China: Stemming the Rising Tide of Non-Communicable Diseases World Bank Report Number 62318-CN 2011 Human Development Unit East Asia and Pacific Region, World Bank Beijing, China
16. China Cardiometabolic Registries (CCMR) Advisory Board. Available at: www.ccmregistry.org. January 2009 to present. Accessed May 2011.
17. World Health Organization Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus 1999 Department of Noncommunicable Disease Surveillance, World Bank Geneva, Switzerland
18. China Society of Diabetes China Guideline for Type 2 Diabetes (2010) 2011 Beijing University Medical Press Beijing, China
19. China Society of Diabetes China Guideline for Type 2 Diabetes (2007) Natl Med J China 18 88 2008 1227 1246
20. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 33 Suppl 1 2010 S62
21. C.Y. Pan, H. Tian, and G.L. Liu Investigation on management of diabetes in city hospitals in China Chin J Endocrinol Metab 5 2004 39 43
22. F. Ning, Z.C. Pang, Y.H. Dong, and Qingdao Diabetes Survey Group Risk factors associated with the dramatic increase in the prevalence of diabetes in the adult Chinese population in Qingdao, China Diabet Med 26 9 2009 855 863
23. H. Tian, G. Song, H. Xie, H. Zhang, J. Tuomilehto, and G. Hu Prevalence of diabetes and impaired fasting glucose among 769,792 rural Chinese adults Diabetes Res Clin Pract 84 3 2009 273 278
24. D. Hu, L. Sun, and P. Fu Prevalence and risk factors for type 2 diabetes mellitus in the Chinese adult population: the InterASIA Study Diabetes Res Clin Pract 84 3 2009 288 295
25. I. Mastura, B.H. Chew, and P.Y. Lee Control and treatment profiles of 70,889 adult type 2 diabetes mellitus patients in Malaysia - a cross sectional survey in 2009 Int J Collab Res Intern Med Public Health 3 2011 98 113
26. C.Y. Pan, W. Yang, W. Jia, J. Weng, and H. Tian Management of Chinese patients with type 2 diabetes, 1998-2006: the Diabcare-China surveys Curr Med Res Opin 25 1 2009 39 45
27. S.H. Saydah, J. Fradkin, and C.C. Cowie Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes JAMA 291 3 2004 335 341
28. K. Wong, D. Glovaci, and S. Malik Comparison of demographic factors and cardiovascular risk factor control among U.S. adults with type 2 diabetes by insulin treatment classification J Diabetes Complications 26 3 2012 169 174
29. M.M. Bała, E. Płaczkiewicz-Jankowska, R. Topór-Madry, and ARETAEUS Study Group Is newly diagnosed type 2 diabetes treated according to the guidelines? Results of the Polish ARETAEUS1 study Pol Arch Med Wewn 121 1-2 2011 7 17
30. K.M. Fox, R.A. Gerber, B. Bolinder, J. Chen, and S. Kumar Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: a series of retrospective analyses of data from 1998 through 2002 Clin Ther 28 2006 388 395
31. Q. Wan, M.F. Harris, and U.W. Jayasinghe Quality of diabetes care and coronary heart disease absolute risk in patients with type 2 diabetes mellitus in Australian general practice Qual Saf Health Care 15 2006 131 135
32. G. Charpentier, N. Genes, and L. Vaur Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey Diabetes Metab 29 2003 152 158
33. B. Lahoz-Rallo, M. Blanco-Gonzalez, and I. Casas-Ciria Cardiovascular disease risk in subjects with type 2 DM in a population in southern Spain Diabetes Res Clin Pract 76 3 2007 436 444
34. O.S. Huang, E.L. Lamoureux, W.T. Tay, E.S. Tai, J.J. Wang, and T.Y. Wong Glycemic and blood pressure control in an Asian Malay population with diabetes and diabetic retinopathy Arch Ophthalmol 128 9 2010 1185 1190
35. M. Comaschi, C. Coselli, and D. Cucinotta Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA study Nutr Metab Cardiovasc Dis 15 3 2005 204 211
36. N.R. Desai, W.H. Shrank, and M.A. Fischer Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications Am J Med 125 3 2012 302.e1 302.e7